{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:39:14Z","timestamp":1793882354140,"version":"4.7.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["YCJJ20242228"],"award-info":[{"award-number":["YCJJ20242228"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72174068"],"award-info":[{"award-number":["72174068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Equity Health"],"DOI":"10.1186\/s12939-024-02368-0","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T20:44:32Z","timestamp":1735850672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Impact of diagnosis-related group payment on medical expenditure and treatment efficiency on people with drug-resistant tuberculosis: a quasi-experimental study design"],"prefix":"10.1186","volume":"24","author":[{"given":"Yingbei","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunhe","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"2368_CR1","unstructured":"Global tuberculosis report 2023. Geneva: World Health Organization; 2023."},{"issue":"10","key":"2368_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","volume":"382","author":"F Conradie","year":"2020","unstructured":"Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, et al. Treatment of highly drug-resistant pulmonary tuberculosis. N Engl J Med. 2020;382(10):893\u2013902.","journal-title":"N Engl J Med"},{"key":"2368_CR3","doi-asserted-by":"crossref","unstructured":"Mirzayev F, Viney K, Linh NN, Gonzalez-Angulo L, Gegia M, Jaramillo E et al. World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update. Eur Respir J 2021;57(6).","DOI":"10.1183\/13993003.03300-2020"},{"issue":"8","key":"2368_CR4","doi-asserted-by":"publisher","first-page":"e2427266","DOI":"10.1001\/jamanetworkopen.2024.27266","volume":"7","author":"T Li","year":"2024","unstructured":"Li T, Zhang B, Du X, Pei S, Jia Z, Zhao Y. Recurrent pulmonary tuberculosis in China, 2005 to 2021. JAMA Netw Open. 2024;7(8):e2427266.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2368_CR5","doi-asserted-by":"publisher","first-page":"e215302","DOI":"10.1001\/jamanetworkopen.2021.5302","volume":"4","author":"H Jiang","year":"2021","unstructured":"Jiang H, Liu M, Zhang Y, Yin J, Li Z, Zhu C, et al. Changes in incidence and epidemiological characteristics of Pulmonary Tuberculosis in Mainland China, 2005\u20132016. JAMA Netw Open. 2021;4(4):e215302.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2368_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5582\/bst.2023.01325","volume":"18","author":"Q Feng","year":"2024","unstructured":"Feng Q, Zhang G, Chen L, Wu H, Yang Y, Gao Q, et al. Roadmap for ending TB in China by 2035: the challenges and strategies. Biosci Trends. 2024;18(1):11\u201320.","journal-title":"Biosci Trends"},{"issue":"5","key":"2368_CR7","doi-asserted-by":"publisher","first-page":"E514","DOI":"10.1016\/S2214-109X(18)30195-5","volume":"6","author":"DJ Carter","year":"2018","unstructured":"Carter DJ, Glaziou P, Lonnroth K, Siroka A, Floyd K, Weil D, et al. The impact of social protection and poverty elimination on global tuberculosis incidence: a statistical modelling analysis of sustainable development goal 1. Lancet Glob Health. 2018;6(5):E514\u201322.","journal-title":"Lancet Glob Health"},{"issue":"10","key":"2368_CR8","doi-asserted-by":"publisher","first-page":"e1640","DOI":"10.1016\/S2214-109X(23)00369-8","volume":"11","author":"A Portnoy","year":"2023","unstructured":"Portnoy A, Yamanaka T, Nguhiu P, Nishikiori N, Garcia Baena I, Floyd K, et al. Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis. Lancet Glob Health. 2023;11(10):e1640\u20137.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"2368_CR9","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1038\/s41467-023-41937-9","volume":"14","author":"NA Menzies","year":"2023","unstructured":"Menzies NA, Allwood BW, Dean AS, Dodd PJ, Houben RMGJ, James LP, et al. Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis. Nat Commun. 2023;14(1):6182.","journal-title":"Nat Commun"},{"issue":"7","key":"2368_CR10","doi-asserted-by":"publisher","first-page":"e002280","DOI":"10.1136\/bmjgh-2019-002280","volume":"5","author":"C Oga-Omenka","year":"2020","unstructured":"Oga-Omenka C, Tseja-Akinrin A, Sen P, Mac-Seing M, Agbaje A, Menzies D, et al. Factors influencing diagnosis and treatment initiation for multidrug-resistant\/rifampicin-resistant tuberculosis in six sub-saharan African countries: a mixed-methods systematic review. BMJ Global Health. 2020;5(7):e002280.","journal-title":"BMJ Global Health"},{"issue":"1","key":"2368_CR11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1186\/s12889-020-09524-5","volume":"20","author":"W Muttamba","year":"2020","unstructured":"Muttamba W, Tumwebaze R, Mugenyi L, Batte C, Sekibira R, Nkolo A, et al. Households experiencing catastrophic costs due to tuberculosis in Uganda: magnitude and cost drivers. BMC Public Health. 2020;20(1):1409.","journal-title":"BMC Public Health"},{"issue":"1","key":"2368_CR12","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/s12889-022-12987-3","volume":"22","author":"AM Kilale","year":"2022","unstructured":"Kilale AM, Pantoja A, Jani B, Range N, Ngowi BJ, Makasi C, et al. Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households. BMC Public Health. 2022;22(1):600.","journal-title":"BMC Public Health"},{"issue":"11","key":"2368_CR13","doi-asserted-by":"publisher","first-page":"923","DOI":"10.5588\/ijtld.21.0182","volume":"25","author":"M Kaswa","year":"2021","unstructured":"Kaswa M, Minga G, Nkiere N, Mingiedi B, Eloko G, Nguhiu P, et al. The economic burden of TB-affected households in DR Congo. int j Tuberc lung dis. 2021;25(11):923\u201332.","journal-title":"int j Tuberc lung dis"},{"issue":"6","key":"2368_CR14","doi-asserted-by":"publisher","first-page":"e036892","DOI":"10.1136\/bmjopen-2020-036892","volume":"10","author":"LF Assebe","year":"2020","unstructured":"Assebe LF, Negussie EK, Jbaily A, Tolla MTT, Johansson KA. Financial burden of HIV and TB among patients in Ethiopia: a cross-sectional survey. BMJ Open. 2020;10(6):e036892.","journal-title":"BMJ Open"},{"issue":"1","key":"2368_CR15","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/s12879-020-05235-9","volume":"20","author":"H Li","year":"2020","unstructured":"Li H, Cheng B, Chen Y. What causes high costs for rural tuberculosis inpatients? Evidence from five counties in China. BMC Infect Dis. 2020;20(1):501.","journal-title":"BMC Infect Dis"},{"key":"2368_CR16","doi-asserted-by":"publisher","first-page":"114292","DOI":"10.1016\/j.jbusres.2023.114292","volume":"169","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen Y, Wang J, Lao Y. The impacts of medical insurance payment methods on medical bills and medical service quality: evidence from Xiangtan, China. J Bus Res. 2023;169:114292.","journal-title":"J Bus Res"},{"key":"2368_CR17","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.2147\/PPA.S389231","volume":"16","author":"X Liu","year":"2022","unstructured":"Liu X, Lin KH, Li YH, Jiang JN, Zhong ZD, Xiong YB, et al. Impacts of Medical Security Level on Treatment outcomes of Drug-resistant tuberculosis: evidence from Wuhan City, China. Patient Prefer Adherence. 2022;16:3341\u201355.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"2368_CR18","doi-asserted-by":"publisher","first-page":"e001029","DOI":"10.1136\/bmjgh-2018-001029","volume":"4","author":"DJ Carter","year":"2019","unstructured":"Carter DJ, Daniel R, Torrens AW, Sanchez MN, Maciel ELN, Bartholomay P, et al. The impact of a cash transfer programme on tuberculosis treatment success rate: a quasi-experimental study in Brazil. BMJ Global Health. 2019;4(1):e001029.","journal-title":"BMJ Global Health"},{"issue":"9","key":"2368_CR19","doi-asserted-by":"publisher","first-page":"e002934","DOI":"10.1136\/bmjgh-2020-002934","volume":"5","author":"D Duran","year":"2020","unstructured":"Duran D, Bauhoff S, Berman P, Gaudet T, Konan C, Ozaltin E, et al. The role of health system context in the design and implementation of performance-based financing: evidence from Cote d\u2019Ivoire. BMJ Global Health. 2020;5(9):e002934.","journal-title":"BMJ Global Health"},{"issue":"1","key":"2368_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41598-021-04345-x","volume":"12","author":"RM Ghazy","year":"2022","unstructured":"Ghazy RM, El Saeh HM, Abdulaziz S, Hammouda EA, Elzorkany AM, Khidr H, et al. A systematic review and meta-analysis of the catastrophic costs incurred by tuberculosis patients. Sci Rep. 2022;12(1):558.","journal-title":"Sci Rep"},{"issue":"4","key":"2368_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.healthpol.2020.01.007","volume":"124","author":"Z Meng","year":"2020","unstructured":"Meng Z, Hui W, Cai Y, Liu J, Wu H. The effects of DRGs-based payment compared with cost-based payment on inpatient healthcare utilization: a systematic review and meta-analysis. Health Policy. 2020;124(4):359\u201367.","journal-title":"Health Policy"},{"issue":"22","key":"2368_CR22","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.3390\/healthcare11222965","volume":"11","author":"W Ma","year":"2023","unstructured":"Ma W, Qu J, Han H, Jiang Z, Chen T, Lu X, et al. Statistical insight into China\u2019s indigenous diagnosis-related-Group System Evolution. Healthcare. 2023;11(22):2965.","journal-title":"Healthcare"},{"key":"2368_CR23","doi-asserted-by":"publisher","first-page":"e6690019","DOI":"10.1155\/2020\/6690019","volume":"2020","author":"D Qiao","year":"2020","unstructured":"Qiao D, Zhang Y, Rehman A, ur, Khosravi MR. Big Data-enabled analysis of DRGs-Based payment on stroke patients in Jiaozuo, China. J Healthc Eng. 2020;2020:e6690019.","journal-title":"J Healthc Eng"},{"key":"2368_CR24","doi-asserted-by":"publisher","first-page":"104990","DOI":"10.1016\/j.healthpol.2023.104990","volume":"141","author":"R Milstein","year":"2024","unstructured":"Milstein R, Schrey\u00f6gg J. The end of an era? Activity-based funding based on diagnosis-related groups: a review of payment reforms in the inpatient sector in 10 high-income countries. Health Policy. 2024;141:104990.","journal-title":"Health Policy"},{"issue":"2","key":"2368_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jss.2016.08.024","volume":"206","author":"TH Kim","year":"2016","unstructured":"Kim TH, Park EC, Jang SI, Jang SY, Lee SA, Choi JW. Effects of diagnosis-related group payment system on appendectomy outcomes. J Surg Res. 2016;206(2):347\u201354.","journal-title":"J Surg Res"},{"issue":"4","key":"2368_CR26","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1111\/1475-6773.12749","volume":"53","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Han K, Kim W, Kim SJ, Park E. Early impact on outpatients of mandatory adoption of the diagnosis-related Group\u2010based reimbursement system in Korea on Use of Outpatient Care: differences in medical utilization and Presurgery Examination. Health Serv Res. 2018;53(4):2064\u201383.","journal-title":"Health Serv Res"},{"issue":"6","key":"2368_CR27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1177\/1010539519872325","volume":"31","author":"C Lee","year":"2019","unstructured":"Lee C, Kim JM, Kim YS, Shin E. The effect of diagnosis-related groups on the Shift of Medical Services from Inpatient to Outpatient settings: a National claims-based analysis. Asia-Pac J Public Health. 2019;31(6):499\u2013509.","journal-title":"Asia-Pac J Public Health"},{"issue":"2","key":"2368_CR28","doi-asserted-by":"publisher","first-page":"e188332","DOI":"10.1001\/jamanetworkopen.2018.8332","volume":"2","author":"A Kutz","year":"2019","unstructured":"Kutz A, Gut L, Ebrahimi F, Wagner U, Schuetz P, Mueller B. Association of the Swiss diagnosis-related group reimbursement system with length of Stay, Mortality, and Readmission Rates in Hospitalized Adult patients. JAMA Netw Open. 2019;2(2):e188332.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2368_CR29","doi-asserted-by":"publisher","first-page":"e2145685","DOI":"10.1001\/jamanetworkopen.2021.45685","volume":"5","author":"Y Wu","year":"2022","unstructured":"Wu Y, Fung H, Shum HM, Zhao S, Wong ELY, Chong KC, et al. Evaluation of length of Stay, Care volume, In-Hospital mortality, and Emergency Readmission Rate Associated with Use of diagnosis-related groups for Internal Resource Allocation in Public Hospitals in Hong Kong. JAMA Netw Open. 2022;5(2):e2145685.","journal-title":"JAMA Netw Open"},{"key":"2368_CR30","doi-asserted-by":"publisher","first-page":"1141981","DOI":"10.3389\/fpubh.2023.1141981","volume":"11","author":"WF Chang","year":"2023","unstructured":"Chang WF, Yan XY, Ling H, Liu T, Luo AJ. A study of the types and manifestations of physicians\u2019 unintended behaviors in the DRG payment system. Front Public Health. 2023;11:1141981.","journal-title":"Front Public Health"},{"issue":"7","key":"2368_CR31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s12603-020-1383-7","volume":"24","author":"LN Peng","year":"2020","unstructured":"Peng LN, Chou YJ, Chen LK, Huang N. Post-acute Use of opioids and psychotropics in patients after hip fracture: unintended consequences of implementing diagnosis-related grouping payment. J Nutr Health Aging. 2020;24(7):745\u201351.","journal-title":"J Nutr Health Aging"},{"key":"2368_CR32","doi-asserted-by":"publisher","first-page":"112590","DOI":"10.1016\/j.socscimed.2019.112590","volume":"243","author":"W Jian","year":"2019","unstructured":"Jian W, Lu M, Liu G, Chan KY, Poon AN. Beijing\u2019s diagnosis-related group payment reform pilot: impact on quality of acute myocardial infarction care. Soc Sci Med. 2019;243:112590.","journal-title":"Soc Sci Med"},{"issue":"8","key":"2368_CR33","doi-asserted-by":"publisher","first-page":"e0220895","DOI":"10.1371\/journal.pone.0220895","volume":"14","author":"MJ Jeon","year":"2019","unstructured":"Jeon MJ, Choo SP, Kwak YH, Kim DW, Kim EH. The effect of diagnosis-related group payment system on the quality of medical care for pelvic organ prolapse in Korean tertiary hospitals. PLoS ONE. 2019;14(8):e0220895.","journal-title":"PLoS ONE"},{"issue":"1","key":"2368_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40249-021-00809-4","volume":"10","author":"Q Long","year":"2021","unstructured":"Long Q, Jiang WX, Zhang H, Cheng J, Tang SL, Wang WB. Multi-source financing for tuberculosis treatment in China: key issues and challenges. Infect Dis Poverty. 2021;10(1):17.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"2368_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40249-016-0102-4","volume":"5","author":"Y Pan","year":"2016","unstructured":"Pan Y, Chen S, Chen M, Zhang P, Long Q, Xiang L, et al. Disparity in reimbursement for tuberculosis care among different health insurance schemes: evidence from three counties in central China. Infect Dis Poverty. 2016;5(1):7.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"2368_CR36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12939-016-0463-0","volume":"15","author":"C Zhou","year":"2016","unstructured":"Zhou C, Long Q, Chen J, Xiang L, Li Q, Tang S, et al. The effect of NCMS on catastrophic health expenditure and impoverishment from Tuberculosis care in China. Int J Equity Health. 2016;15(1):172.","journal-title":"Int J Equity Health"},{"issue":"1","key":"2368_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40249-016-0099-8","volume":"5","author":"X Jia","year":"2016","unstructured":"Jia X, Chen J, Zhang S, Dai B, Long Q, Tang S. Implementing a free tuberculosis (TB) care policy under the integrated model in Jiangsu, China: practices and costs in the real world. Infect Dis Poverty. 2016;5(1):1.","journal-title":"Infect Dis Poverty"},{"key":"2368_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40249-015-0094-5","volume":"5","author":"L Xiang","year":"2016","unstructured":"Xiang L, Pan Y, Hou S, Zhang H, Sato KD, Li Q, et al. The impact of the new cooperative medical scheme on financial burden of tuberculosis patients: evidence from six counties in China. Infect Dis Poverty. 2016;5:8.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"2368_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40249-019-0532-x","volume":"8","author":"WX Jiang","year":"2019","unstructured":"Jiang WX, Long Q, Lucas H, Dong D, Chen JY, Xiang L, et al. Impact of an innovative financing and payment model on tuberculosis patients\u2019 financial burden: is Tuberculosis care more affordable for the poor? Infect Dis Poverty. 2019;8(1):21.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"2368_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40249-019-0559-z","volume":"8","author":"D Dong","year":"2019","unstructured":"Dong D, Jiang WX, Long Q, Huang F, Zhang H, Chen JY, et al. Impact of an innovative tuberculosis financing and payment model on health service utilization by Tuberculosis patients in China: do the poor fare better than the rich? Infect Dis Poverty. 2019;8(1):44.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"2368_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40249-019-0590-0","volume":"8","author":"XX Wang","year":"2019","unstructured":"Wang XX, Chen JY, Jiang H, Zhu AN, Long Q, Ji JS. Utilization and expenses of outpatient services among tuberculosis patients in three Chinese counties: an observational comparison study. Infect Dis Poverty. 2019;8(1):79.","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"2368_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40249-021-00861-0","volume":"10","author":"XY Hu","year":"2021","unstructured":"Hu XY, Gao GY. Evaluation of the effect of the capitation compensation mechanism among pulmonary tuberculosis patients with a full period of treatment. Infect Dis Poverty. 2021;10(1):78.","journal-title":"Infect Dis Poverty"},{"key":"2368_CR43","doi-asserted-by":"publisher","first-page":"114601","DOI":"10.1016\/j.socscimed.2021.114601","volume":"292","author":"Y Lai","year":"2022","unstructured":"Lai Y, Fu H, Li L, Yip W. Hospital response to a case-based payment scheme under regional global budget: the case of Guangzhou in China. Soc Sci Med. 2022;292:114601.","journal-title":"Soc Sci Med"},{"issue":"1","key":"2368_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12939-024-02134-2","volume":"23","author":"L Zhang","year":"2024","unstructured":"Zhang L, Sha W, Lin Q, Fang Y. Can single disease payment impact hospitalization expenses and quality in district hospital? A case study in Fujian, China. Int J Equity Health. 2024;23(1):53.","journal-title":"Int J Equity Health"},{"issue":"10","key":"2368_CR45","doi-asserted-by":"publisher","first-page":"e036985","DOI":"10.1136\/bmjopen-2020-036985","volume":"10","author":"S Wen","year":"2020","unstructured":"Wen S, Yin J, Sun Q. Impacts of social support on the treatment outcomes of drug-resistant tuberculosis: a systematic review and meta-analysis. BMJ Open. 2020;10(10):e036985.","journal-title":"BMJ Open"},{"issue":"7","key":"2368_CR46","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/MLR.0b013e31817a835d","volume":"46","author":"RM Andersen","year":"2008","unstructured":"Andersen RM. National Health Surveys and the behavioral model of Health services Use. Med Care. 2008;46(7):647.","journal-title":"Med Care"},{"issue":"6","key":"2368_CR47","doi-asserted-by":"publisher","first-page":"S345","DOI":"10.1093\/geronj\/46.6.S345","volume":"46","author":"FD Wolinsky","year":"1991","unstructured":"Wolinsky FD, Johnson RJ. The Use of Health services by older adults. J Gerontol. 1991;46(6):S345\u201357.","journal-title":"J Gerontol"},{"issue":"5","key":"2368_CR48","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"4","key":"2368_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/1536867X0200200403","volume":"2","author":"SO Becker","year":"2002","unstructured":"Becker SO, Ichino A. Estimation of Average Treatment effects based on propensity scores. Stata J. 2002;2(4):358\u201377.","journal-title":"Stata J"},{"key":"2368_CR50","doi-asserted-by":"publisher","first-page":"114415","DOI":"10.1016\/j.socscimed.2021.114415","volume":"289","author":"M Qian","year":"2021","unstructured":"Qian M, Zhang X, Chen Y, Xu S, Ying X. The pilot of a new patient classification-based payment system in China: the impact on costs, length of stay and quality. Soc Sci Med. 2021;289:114415.","journal-title":"Soc Sci Med"},{"issue":"2","key":"2368_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/hec.1361","volume":"18","author":"P Boeckerman","year":"2009","unstructured":"Boeckerman P, Ilmakunnas P. Unemployment and self-assessed health: evidence from Panel Data. Health Econ. 2009;18(2):161\u201379.","journal-title":"Health Econ"},{"issue":"1","key":"2368_CR52","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1080\/22221751.2021.1931467","volume":"10","author":"Q Li","year":"2021","unstructured":"Li Q, Wang L, Wang B, Lu H. The COVID-19-designated hospitals in China: preparing for public health emergencies. Emerg Microbes Infect. 2021;10(1):998\u20131001.","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"2368_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12992-021-00665-9","volume":"17","author":"S Sun","year":"2021","unstructured":"Sun S, Xie Z, Yu K, Jiang B, Zheng S, Pan X. COVID-19 and healthcare system in China: challenges and progression for a sustainable future. Global Health. 2021;17(1):14.","journal-title":"Global Health"},{"issue":"5","key":"2368_CR54","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/heapol\/czae022","volume":"39","author":"X Zhang","year":"2024","unstructured":"Zhang X, Tang S, Wang R, Qian M, Ying X, Maciejewski ML. Hospital response to a new case-based payment system in China: the patient selection effect. Health Policy Plann. 2024;39(5):519\u201327.","journal-title":"Health Policy Plann"},{"key":"2368_CR55","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/S0140-6736(15)00604-2","volume":"386","author":"W Jian","year":"2015","unstructured":"Jian W, Lu M, Chan KY, Poon AN, Han W, Hu M, et al. The impact of a pilot reform on the diagnosis-related-groups payment system in China: a difference-in-difference study. Lancet. 2015;386:S26.","journal-title":"Lancet"},{"key":"2368_CR56","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2147\/RMHP.S376516","volume":"15","author":"T Zhang","year":"2022","unstructured":"Zhang T, Lu B, Yan Z, Huang X, Lu W. Impacts of a New Episode-based payment Scheme on volume, expenditures, and Efficiency in Public hospitals: a quasi-experimental interrupted time-series study in Jinhua. China RMHP. 2022;15:1659\u201369.","journal-title":"China RMHP"},{"issue":"23","key":"2368_CR57","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1056\/NEJM199206043262302","volume":"326","author":"R Edlin Brian","year":"1992","unstructured":"Edlin Brian R, Tokars Jerome I, Grieco Michael H, Crawford Jack T, Julie W, Emelia S. An outbreak of Multidrug-resistant tuberculosis among hospitalized patients with the Acquired Immunodeficiency Syndrome. N Engl J Med. 1992;326(23):1514\u201321.","journal-title":"N Engl J Med"},{"issue":"15","key":"2368_CR58","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1001\/archinte.1995.00430150057006","volume":"155","author":"RE Brown","year":"1995","unstructured":"Brown RE, Miller B, Taylor WR, Palmer C, Bosco L, Nicola RM, et al. Health-Care expenditures for tuberculosis in the United States. Arch Intern Med. 1995;155(15):1595\u2013600.","journal-title":"Arch Intern Med"},{"issue":"10","key":"2368_CR59","first-page":"733","volume":"42","author":"[Chinese expert consensus on multidrug-resistant tuberculosis and Rifampicin-resistant tuberculosis treatment]","year":"2019","unstructured":"[Chinese expert consensus on multidrug-resistant tuberculosis and Rifampicin-resistant tuberculosis treatment]. Zhonghua Jie He He Hu Xi Za Zhi. 2019;42(10):733\u201349.","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"2368_CR60","doi-asserted-by":"publisher","first-page":"204993612110169","DOI":"10.1177\/20499361211016973","volume":"8","author":"S Kant","year":"2021","unstructured":"Kant S, Tyagi R. The impact of COVID-19 on tuberculosis: challenges and opportunities. Therapeutic Adv Infect Disease. 2021;8:20499361211016973.","journal-title":"Therapeutic Adv Infect Disease"}],"container-title":["International Journal for Equity in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-024-02368-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12939-024-02368-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12939-024-02368-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:02:26Z","timestamp":1735851746000},"score":1,"resource":{"primary":{"URL":"https:\/\/equityhealthj.biomedcentral.com\/articles\/10.1186\/s12939-024-02368-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2368"],"URL":"https:\/\/doi.org\/10.1186\/s12939-024-02368-0","relation":{},"ISSN":["1475-9276"],"issn-type":[{"value":"1475-9276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research involving human data has been performed in accordance with the Declaration of Helsinki. All methods were carried out in accordance with relevant guidelines and regulations in the declaration. The study was approved by the institutional review board at each participating site and by the biomedical ethics review committee of Huazhong University of Science and Technology (S170. June 30, 2021). The need for informed consent was waived by the ethics institutional review board of Huazhong University of Science and Technology because of the retrospective nature of the study. All authors confirm that this research caused no harm (physical or mental) to any participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there were no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}